Synthetic Cannabis
Historically, a group of compounds originally developed by several
medical/pharmacy researchers.
Currently there is no approved medical use for any of these products.
-
Classification: Hallucinogenic, marijuana-like, “ psychoactive designer drugs”
-
Availability: Leafy plant material commonly sold in brightly colored foil packaging containing from 2 to 12 grams, or small plastic jars. Sold in convenience stores, head shops and online
-
Observed Behavior: Expected marijuana-like high with negative effects
-
Observed negative effects: Anxiety, nausea, hypertension, severe paranoia, agitation, hallucinations, delusions, dilated pupils, heart palpitations, panic attacks, respiratory issues, heart attack, convulsions
-
Street Names:
-
K-2
-
Spice
-
Black Mamba
-
Fake Weed
-
Genie
-
Blaze
-
JWH
-
Skunk
-
Street Pricing: Can be from a few dollars to twenty dollars per
unit package
Drug
Schedule: The synthetic cannabinmimetic compounds
are Schedule I in Connecticut effective April 24, 2012
-
21a-243-7(f) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of a substance having a psychotropic response primarily by agonist activity at cannabinoid-specific receptors affecting the central nervous system. Specific compounds include, but are not limited to:
-
1-pentyl-3-(1-naphthoyl)indole (JWH-018)
-
1-butyl-3-(1-naphtholy)indole (JWH-073)
-
1-[2-(4-morpholynyl)ethyl]-3-(1-naphthoyl)indole (JWH-200)
-
5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP-47497)
-
5-(1,1-dimethylheptyl)-2-(1R,3S)-3-hydroxycyclohexyl]-phenol(cannabicyclohexanol CP-47,497 C* homologue).
-
-
Charges: These drugs are classified as Cannabinmimetic Agents in the Designer Drug-Hallucinogen Drug Type
-
Sale - Any quantity regardless of drug dependency is 21a-277(a)
-
Sale - Any quantity for a not drug dependent person is 21a-278(b)
-
Possession - Any quantity regardless of drug dependency 21a-279(b)
-
